← Leaderboards
Krystle Anne Frahm
University Of Pittsburgh At Pittsburgh
$1,647,529
Attributed
$1,647,529
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $396.9K · FY2013–23$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,647,529 · 4
By mechanism
K01$796,337 · 1
R21$586,875 · 1
R03$237,407 · 1
F31$26,910 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Ryan Lee Minster$6,529,066
- Martica Helon Hall$9,756,546
- Tony M Plant$8,137,866
- Mingui Sun$11,879,919
- Abhiram Sahu$3,306,388
Others in their field
Top investigators on “Samoan”
- Stephen T. McGarvey · Brown University$14,780,992
- Ryan Lee Minster · University Of Pittsburgh At Pittsburgh$6,529,066
- Van My Ta Park · University Of Pennsylvania$6,517,598
- Vaatausili T Tofaeono · American Samoa Community Cancer Coalitio$5,518,936
- Sora Park Tanjasiri · California State University Fullerton$5,483,901
- James E Galvin · Weill Medical Coll Of Cornell Univ$5,146,741
Research focus
SamoanCreb3 GeneResearch PersonnelRisk VariantVariantPhenotypeNeuronsRegulationResponseHypothalamic StructureUnited States National Institutes Of HealthGenetic TranscriptionMissionOutputGenome-Wide AnalysisGenesPublic HealthMouse ModelObesityCellsDisorder PreventionBody WeightLinkMolecular
Grant awards (12)
The Role of CREBRF on Hypothalamic Function$119,250
R03 · FY2023 · DK · contact PI
The Role of CREBRF on Hypothalamic Function$118,157
R03 · FY2022 · DK · contact PI
The Role of a Novel Obesity-Risk Variant on Hypothalamic Regulation of Energy Homeostasis$195,625
R21 · FY2021 · DK · contact PI
Impact of CREBRF and its obesity-risk variant on hypothalamic glucocorticoid and neuroendocrine output using molecular, cellular, and physiological approaches.$148,403
K01 · FY2021 · DK · contact PI
Impact of CREBRF and its obesity-risk variant on hypothalamic glucocorticoid and neuroendocrine output using molecular, cellular, and physiological approaches.$52,822
K01 · FY2021 · DK · contact PI
The Role of a Novel Obesity-Risk Variant on Hypothalamic Regulation of Energy Homeostasis$195,625
R21 · FY2020 · DK · contact PI
Impact of CREBRF and its obesity-risk variant on hypothalamic glucocorticoid and neuroendocrine output using molecular, cellular, and physiological approaches.$148,403
K01 · FY2020 · DK · contact PI
The Role of a Novel Obesity-Risk Variant on Hypothalamic Regulation of Energy Homeostasis$195,625
R21 · FY2019 · DK · contact PI
Impact of CREBRF and its obesity-risk variant on hypothalamic glucocorticoid and neuroendocrine output using molecular, cellular, and physiological approaches.$148,403
K01 · FY2019 · DK · contact PI
Impact of CREBRF and its obesity-risk variant on hypothalamic glucocorticoid and neuroendocrine output using molecular, cellular, and physiological approaches.$148,403
K01 · FY2018 · DK · contact PI
Impact of CREBRF and its obesity-risk variant on hypothalamic glucocorticoid and neuroendocrine output using molecular, cellular, and physiological approaches.$149,903
K01 · FY2017 · DK · contact PI
Increased Prenatal Glucocorticoids on Vascularization in the Paraventricular Nucl$26,910
F31 · FY2013 · HD · contact PI